CC

Cancer Cell International

Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments).

Looking to publish in Cancer Cell International? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 6
Quartile Q1
Open Access Type Open
eISSN 1475-2867
Invitation Only No
Cost Range APC: £2490.00 GBP / $3290.00 USD / €2790.00 EUR, plus VAT or local taxes where applicable.

Submission Instructions

Cancer Cell International accepts the following article types. Click on an article type to view submission instructions.

Research

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, and confirm the content has not been published or submitted elsewhere.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Methods, Results, and Conclusions, and if reporting a health care intervention on human participants it must also include a Trial registration section with registration number and date and state 'retrospectively registered' if applicable.
Manuscript Manuscript must include a Methods section covering the aim, design and setting of the study, participant characteristics or materials, and all processes, interventions and comparisons, and must include a 'Declarations' section with all required subheadings. Manuscript must include three to ten keywords, a list of abbreviations if abbreviations are used, documentation of any Large Language Model use in the Methods or another suitable section, and under 'Declarations' the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, Acknowledgements, and optional Authors' information, using 'Not applicable' where a section is not relevant.
References Only published articles, clinical trial registration records, and publicly available abstracts or e-prints/preprints may be cited; unpublished abstracts, unpublished data, and personal communications must not appear in the reference list; journal abbreviations must follow Index Medicus/MEDLINE; and web links or URLs must be assigned a reference number and included in the reference list in full with title, URL, and access date.
Figures & Tables Figure titles and legends must be included in the main manuscript rather than the graphic file; tables under one page may be placed within the manuscript and larger tables may be placed at the end of the document; and supplemental data must be cited in the main text. Figures must be numbered in order of first mention, multi-panel figures submitted as single composite files, source data included for any tumour-growth figures, and tables must be numbered in sequence and created with the word processor's table function rather than embedded as figures or spreadsheet files.
Reformat to Cancer Cell International using Livewrite Premium

Review

Cover Letter A cover letter is required. The cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, and confirm the content has not been published or submitted elsewhere.
Abstract An abstract is required. The abstract must not exceed 350 words. The abstract must be structured. The abstract must include Background, Main body of the abstract, and short Conclusion.
Manuscript Reviews should be approximately 3000 words. The manuscript must include Background, Main text, Conclusions, and a Declarations section. Review manuscripts must include three to ten keywords, a list of abbreviations if abbreviations are used, a Declarations section with the specified subheadings including 'Not applicable' where relevant, an Availability of data and materials statement, and documentation of any Large Language Model use in the Methods section or another suitable section if no Methods section is available.
References References must follow Vancouver reference style. Only published, in-press, or publicly available preprint articles, clinical trial registration records, and abstracts may be cited; unpublished abstracts, unpublished data, and personal communications must not appear in the reference list; journal abbreviations must follow Index Medicus/MEDLINE; and web links must be assigned a reference number and included in the reference list in full.
Figures & Tables Tables less than one page may be placed within the manuscript, tables larger than one page may be placed at the end of the document with their intended location indicated in the text, figure titles and legends must appear in the main manuscript, and figures must be uploaded separately in the order first cited. Multi-panel figures must be submitted as a single composite file, tables must be created using the table function rather than embedded as figures or spreadsheet files, and footnotes must not contain figures or tables.
Reformat to Cancer Cell International using Livewrite Premium

Comment

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published, address any journal policy issues, declare any potential competing interests, and confirm that all authors approved the submission and that the content is not published or under consideration elsewhere.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include Background, Main body of the abstract, and short Conclusion.
Manuscript Manuscript must include a title page, a Main text section with Background and Conclusions sections, and a Declarations section. Manuscript must include 3 to 10 keywords and a Declarations section containing the headings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, Acknowledgements, and Authors' information, with 'Not applicable' used where a section is not relevant.
References References must follow Vancouver style. References must not be cited in the abstract.
Figures & Tables Tables shorter than one page may be placed in the manuscript near their citation, while tables longer than one page may be placed at the end of the document and figures must be uploaded separately. Figure titles and legends must be included in the manuscript rather than the figure file, and footnotes must not contain figures or tables.
Reformat to Cancer Cell International using Livewrite Premium

Recent Publications

Single-cell and bulk omics uncover fibroblast heterogeneity and HSPH1 as a key driver in Barrett’s esophagus to esophageal adenocarcinoma progression

Lulong Tao, Yanting Guo, Fang Lu, Changyong Qi, Guoxin Zhang, Jin Yan

10.1186/s12935-026-04319-x
View Publication

PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma

Xing Ji, Yongyang Yun, Zhenpeng Zhu, Tianyu Wu, Mingjian Ruan, Yu Fan, Qian Zhang

10.1186/s12935-026-04266-7
View Publication

FAK inhibitor suppresses ovarian cancer growth by inhibiting tumor angiogenesis

Jingtian Shen, Zhiru Su, Yihan Shan, Ying Wang, Yi Meng, Zhiling Li, Shuping Miao, Jinyi Zhang, Xiaojian Yan

10.1186/s12935-026-04325-z
View Publication

Multi-omics analysis of the mechanism by ATP13A2 regulates the tumor microenvironment and prognosis in hepatocellular carcinoma

Yijie Weng, Changan Chen, Yueqing Cai, Feifei Gao, Jiahua Situ, Jiajian Wu, Guixia Zhang, Xintian Chen, Danxian Jiang

10.1186/s12935-026-04315-1
View Publication

Integrated analyses reveal a potential role for PFKFB4 in M2 macrophage polarization and hepatocellular carcinoma progression

Siying Wang, Qinqiu Zhang, Tian Li, Zibo Xu, Zhaoxia Wang, Xuyu Chen, Chen chen Wei

10.1186/s12935-026-04326-y
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision (median): 38 days.

Reformat to Cancer Cell International using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should explain why the manuscript should be published in Cancer Cell International, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, confirm the work has not been published or submitted elsewhere, and identify the special issue name if applicable. Authors may also suggest preferred or non-preferred reviewers in the cover letter.

Reformat to Cancer Cell International using Livewrite Premium

What are the publication costs?

An article processing charge applies for each accepted article. The current APC is £2490.00 GBP / $3290.00 USD / €2790.00 EUR, plus VAT or local taxes where applicable.

Reformat to Cancer Cell International using Livewrite Premium

Research Topics

Cancer-related molecular mechanisms research MicroRNA in disease regulation RNA modifications and cancer Circular RNAs in diseases Ferroptosis and cancer prognosis Epigenetics and DNA Methylation Cancer Cells and Metastasis Cancer, Hypoxia, and Metabolism RNA Research and Splicing Cancer Immunotherapy and Biomarkers Cancer-related gene regulation Cancer, Lipids, and Metabolism Cancer-related Molecular Pathways Ubiquitin and proteasome pathways Immunotherapy and Immune Responses Cancer Mechanisms and Therapy Cancer Genomics and Diagnostics Immune cells in cancer Autophagy in Disease and Therapy Extracellular vesicles in disease Peptidase Inhibition and Analysis Pancreatic and Hepatic Oncology Research Cancer Research and Treatments Immune Cell Function and Interaction CAR-T cell therapy research

Related Journals

MM
Military Medical Research BioMed Central
BA
Bmc Anesthesiology BioMed Central
IJ
International Journal Of Cancer WILEY
IJ
Israel Journal Of Health Policy Research BioMed Central
MC
Molecular Cancer Therapeutics American Association for Cancer Research
BR
Biomarker Research BioMed Central